Newark Beth Israel Medical Center’s First Annual Victor Parsonnet, MD, Cardiovascular Lecture will be delivered on Saturday, September 29 at 8:00 am in the hospital’s Parsonnet-Danzis Auditorium. Frank Veith, MD, Professor of Surgery at NYU Medical Center and Professor of Surgery at the Cleveland Clinic, will present a program titled Carotid Surgery or Carotid Stent: the CREST Trial is Misleading.” To learn more or to register, contact Debra Cook, Research Coordinator and Fellowship Coordinator at Newark Beth Israel Medical Center, at 973-926-8128 or email@example.com.
The program, which offers continuing medical education (CME) credits for physicians, will give healthcare professionals insight into the results and conclusions of randomized clinical trials such as the Carotid Revascularization Endarterectomy vs. Stenting (CREST) study that began in 2000 and has since spurred several related clinical research trials. The purpose of the CREST trial, which physicians and patients at Newark Beth Israel Medical Center participated in, was to compare stent-assisted carotid angioplasty to the traditional and accepted surgical approach of carotid endarterectomy for the treatment of blockages in the carotid arteries.
“Cardiovascular physicians still debate which treatment option is most appropriate for individual patients with carotid stenosis and other cardiovascular diseases,” said Bruce Brener, MD, Director of the Barnabas Health Vascular Center, Director of Vascular Surgery and the Vascular Fellowship Program, and Medical Director of the Vascular Lab at Newark Beth Israel Medical Center. “Dr. Veith will illustrate how the CREST trial and other randomized clinical trials can be both misleading and helpful in assisting physicians determine the best treatment option for their patients,” he stated.
Frank Veith, MD, Professor of Surgery at NYU Medical Center and Professor of Surgery at the Cleveland Clinic, has received numerous awards and honors as a leader, teacher and innovator in vascular surgery. He initially achieved professional success in his work in lung transplantation. Then, in the 1970s and 80s he turned his attention to vascular surgery with emphasis on lower extremity revascularization procedures and the endovascular graft repair of abdominal aortic aneurysms. Dr Veith’s group was the first in the United States to perform an endovascular aneurysm repair in 1992.
Dr. Veith served as Chief of Vascular Surgery and Chairman of Surgery at Montefiore Medical Center and Albert Einstein College of Medicine for many years. He was also the William J. Von Liebig Chair in Vascular Surgery at the Cleveland Clinic. He is a leading advocate for the recognition of vascular surgery as a separate and distinct specialty. He has held leadership positions in every national and many international professional vascular associations. In 1995 he was elected President of the Society for Vascular Surgery and currently serves as Chairman of the American Board of Vascular Surgery.
Newark Beth Israel Medical Center’s annual Victor Parsonnet, MD, Lecture was established in honor of the accomplished surgeon and researcher. Dr. Parsonnet, Medical Director of Pacemaker and Defibrillator Evaluation and Director of Surgical Research, has demonstrated a lifetime of commitment and service to the advancement of cardiovascular medicine and surgery. He holds five patents and gained international renown for his work with pacemakers. He was the first to implant a permanent transvenous pacemaker and the first in the United States to implant a nuclear pacemaker and later the first lithium pacemaker. Dr. Parsonnet also pioneered many cardiovascular procedures in NJ, such as the first aortocoronary by-pass operation and he performed the state’s first kidney and heart transplants.
Contact: Caren Malone
Public Relations Department
top ] [ back to News Index ]